Neumora Therapeutics (NMRA) Other Accumulated Expenses (2022 - 2026)
Neumora Therapeutics' Other Accumulated Expenses came in at $571,000 for Q2 2026, up 26.9% from $450,000 a year earlier but down 22.4% from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Other Accumulated Expenses (2022 - 2026) Analysis & Trends
At the end of FY2025, Neumora Therapeutics' Other Accumulated Expenses was $724,000, up 122.1% from FY2024.
- Other Accumulated Expenses carries a three-year compound annual growth rate of 21.1% (FY2022 to FY2025).
- Going back by year, Other Accumulated Expenses was $326,000 in FY2024 (-56.5%), $750,000 in FY2023 (+83.8%) and $408,000 in FY2022.
- The five-year range for quarterly Other Accumulated Expenses is $326,000 (Q4 2024) to $750,000 (Q4 2023).
- Year-over-year, Other Accumulated Expenses has increased for five consecutive quarters, with growth averaging 23.7% over the last eight quarters.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q4 2025 (growth of 122.1%), and the weakest in Q4 2024 (a decline of 56.5%).
- Business Quant data shows NMRA's Other Accumulated Expenses at $736,000 (Q1 2026), $724,000 (Q4 2025) and $449,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Neumora Therapeutics | 112.74 Mn | 112.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 571,000.00 |
| Mar 31, 2026 | 736,000.00 |
| Dec 31, 2025 | 724,000.00 |
| Sep 30, 2025 | 449,000.00 |
| Jun 30, 2025 | 450,000.00 |
| Mar 31, 2025 | 409,000.00 |
| Dec 31, 2024 | 326,000.00 |
| Sep 30, 2024 | 392,000.00 |
| Jun 30, 2024 | 366,000.00 |
| Mar 31, 2024 | 542,000.00 |
| Dec 31, 2023 | 750,000.00 |
| Sep 30, 2023 | 375,000.00 |
| Dec 31, 2022 | 408,000.00 |
API Access
Neumora Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();